NCT05206110View on ClinicalTrials.gov

Low Dose Versus Normal Dose Ketorolac for Postoperative Pain After Prostatectomy and Hysterectomy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

September 5, 2024

Study Completion Date

December 31, 2024

Conditions
AnesthesiaSurgery
Interventions
DRUG

10 mg IV ketorolac

Patients undergoing LAVH, RARP or TLH will receive half an hour before the end of surgery, 10 mg ketorolac (IV). Also, 10 mg IV ketorolac will be given 8h and 16h after the surgery

DRUG

30 mg IV ketorolac

Patients undergoing LAVH, RARP or TLH will receive half an hour before the end of surgery, 30 mg ketorolac (IV). Also, 30 mg ketorolac will be given 8h and 16h after the surgery

Trial Locations (1)

3500

Jessa hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER